Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41,061,008
-
Total 13F shares
-
4,190,412
-
Share change
-
+5,445
-
Total reported value
-
$29,539,000
-
Price per share
-
$7.02
-
Number of holders
-
8
-
Value change
-
+$36,896
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q1 2022
As of 31 Mar 2022 Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,190,412 shares of stock of the company.
Largest 8 holders included 22NW, LP, MANGROVE PARTNERS, Laurion Capital Management LP, Ikarian Capital, LLC, BOOTHBAY FUND MANAGEMENT, LLC, BlackRock Inc., UBS Group AG, and Tower Research Capital LLC (TRC).
This table shows 8 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.